Co-Chair of the HB-HTA group

1.08.2022

Iga Lipska, Ph.D.

Iga Lipska, Ph.D., acting from the beginning of July 2022 as Deputy Director of the Clinical Research Support Centre of the MUG, became the Co-Chair of the HB-HTA (Hospital-Based Health Technology Assessment) working group operating within the Health Technology Assessment international organization. The second Co-Chair of the HB-HTA group became Rosella Di Bidino, Ph.D. from the Policlinico Universitario Agostino Gemelli in Rome.

At the meeting of the HB-HTA working group held on 27th of June 2022 in Utrecht, Iga Lipska, Ph.D. presented the results of the project Implementation of the Hospital-Based HTA – Hospital Assessment of Innovative Medical Technologies, finansed by the National Centre for Research and Development. The project, led by Dr. Lipska, was carried out by a consortium composed of the National Health Fund, the Lazarski University and the Cardinal Stefan Wyszynski National Institute of Cardiology.

Health Technology Assessment is a recognized international organization with a global reach. The MUG’s specialist has been participating in the work of the HTA since 2004, taking part as a speaker in panel sessions and plenary sessions at conferences, incl. in Montreal, Dublin, Seoul and Rome.

photo Paweł Sudara/MUG